Sitting Down With... Brian Overstreet, President at Advera Health Analytics, USA.

Does incentivizing informants deter off-label drug marketing ? Should other countries follow suit?

The combination of genomic profiling and high-tech targeted drug delivery is opening up a new front in the fight against cancer.

The stability of drug formulations is essential. But what should be monitored – and how often?

New drug delivery technologies have their place, but so too do traditional needle injections…

Translating medicine packaging information for international markets is a major challenge.

3D printing is starting to sound attractive - but we really need to understand our powders.

Neonates have been underserved, potentially missing out on life-giving scientific advances.

Regulators come down hard on facilities that come up short.

Documents reveal that Turing and Valeant both used PR to divert attention from drug price hikes